{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=5&status=RECRUITING", "query": { "status": "RECRUITING", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 22008, "total_pages": 2201, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=6&status=RECRUITING&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=4&status=RECRUITING&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T15:34:37.378Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06116110", "title": "Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Non Hodgkin Lymphoma", "Refractory Diffuse Large B Cell Lymphoma (DLBCL)", "Relapsed Diffuse Large B Cell Lymphoma", "High Grade B-cell Lymphoma", "Central Nervous System Lymphoma", "Primary Mediastinal B-cell Lymphoma (PMBCL)" ], "interventions": [ { "name": "Long-term Follow-Up", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Miltenyi Biomedicine GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2024-05-15", "completion_date": "2041-12-01", "has_results": false, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 11, "location_summary": "Gilbert, Arizona • Stanford, California • New Haven, Connecticut + 8 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Stanford", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Westwood", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06116110" }, { "nct_id": "NCT06693310", "title": "STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ulcerative Colitis (UC)" ], "interventions": [ { "name": "de-escalation or discontinuation of therapy", "type": "OTHER" }, { "name": "continuation of current therapy", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 200, "start_date": "2025-11-11", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06693310" }, { "nct_id": "NCT07763210", "title": "Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-hodgkin Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Mantle Cell Lymphoma", "Refractory Mantle Cell Lymphoma", "Refractory Marginal Zone Lymphoma" ], "interventions": [ { "name": "Therapeutic Hydrocortisone", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Axicabtagene Ciloleucel", "type": "BIOLOGICAL" }, { "name": "Brexucabtagene Autoleucel", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2026-09-25", "completion_date": "2029-10-01", "has_results": false, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07763210" }, { "nct_id": "NCT06846320", "title": "Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Generalized Anxiety Disorder (GAD)" ], "interventions": [ { "name": "ABBV-932", "type": "DRUG" }, { "name": "Placebo for ABBV-932", "type": "DRUG" }, { "name": "Antidepressant Therapy (ADT)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 315, "start_date": "2025-04-29", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 49, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Tucson, Arizona + 43 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Colton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06846320" }, { "nct_id": "NCT05989620", "title": "Long-Term Development of Muscular Dystrophy Outcome Assessments", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "LGMD1B", "LGMD1C", "LGMD1D", "LGMD1E", "LGMD1F", "LGMD1G", "LGMD1H", "LGMD2A", "LGMD2B", "LGMD2C", "LGMD2D", "LGMD2E", "LGMD2F", "LGMD2G", "LGMD2I", "LGMD2J", "LGMD2K", "LGMD2L", "LGMD2M", "LGMD2N", "LGMD2O", "LGMD2P", "LGMD2Q", "LGMD2S", "LGMD2T", "LGMD2U", "LGMD2W", "LGMD2X", "LGMD2Y" ], "interventions": [], "intervention_types": [], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "6 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "6 Years to 50 Years" }, "enrollment_count": 1000, "start_date": "2023-10-18", "completion_date": "2029-05-01", "has_results": false, "last_update_posted_date": "2025-11-18", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05989620" }, { "nct_id": "NCT05251324", "title": "The Cardiovascular Impact of Hot Flushes", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hot Flashes", "Menopause" ], "interventions": [ { "name": "Hot Flush Induction", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "40 Years to 70 Years · Female only" }, "enrollment_count": 60, "start_date": "2022-03-01", "completion_date": "2027-05-26", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05251324" }, { "nct_id": "NCT07227324", "title": "Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cannabis Use", "Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "HealthPartners Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2025-08-26", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Saint Louis Park, Minnesota", "locations": [ { "city": "Saint Louis Park", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227324" }, { "nct_id": "NCT03932279", "title": "Characterization of the Microbiome in Cutaneous T Cell Lymphoma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cutaneous T Cell Lymphoma" ], "interventions": [], "intervention_types": [], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 300, "start_date": "2019-01-30", "completion_date": "2028-08-31", "has_results": false, "last_update_posted_date": "2026-05-01", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03932279" }, { "nct_id": "NCT06454188", "title": "A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriatic Arthritis", "Spondyloarthritis, Axial" ], "interventions": [ { "name": "Upadacitinib 15 MG [Rinvoq]", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CARE ARTHRITIS LTD.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2024-12-03", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-04-03", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 3, "location_summary": "Cleveland, Ohio • Portland, Oregon • Philadelphia, Pennsylvania", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06454188" }, { "nct_id": "NCT03932903", "title": "Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma" ], "interventions": [ { "name": "ADAPTS (ADherence Assessments and Personalized Timely Support).", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "ALL", "summary": "14 Years and older" }, "enrollment_count": 60, "start_date": "2025-07-31", "completion_date": "2027-08-31", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-10-07T15:34:37.378Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03932903" } ] }